Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2).
Lancet
; 399(10343): 2267-2279, 2022 06 18.
Article
in En
| MEDLINE
| ID: mdl-35717987
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Endometriosis
Type of study:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Lancet
Year:
2022
Document type:
Article